Evaluation of early conversion to prolonged-release tacrolimus in lung transplantation.

M. Entrenas Castillo (Cordoba, Spain), I. OrdoñEz Dios (Cordoba, Spain), F. Montoro Ballesteros (Cordoba, Spain), J. Redel Montero (Cordoba, Spain), M. Cobos Ceballos (Cordoba, Spain), F. Santos Luna (Cordoba, Spain), J. Vaquero Barrios (Cordoba, Spain)

Source: International Congress 2018 – Moving lung transplantation forward
Session: Moving lung transplantation forward
Session type: Thematic Poster
Number: 2600
Disease area: Pulmonary vascular diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Entrenas Castillo (Cordoba, Spain), I. OrdoñEz Dios (Cordoba, Spain), F. Montoro Ballesteros (Cordoba, Spain), J. Redel Montero (Cordoba, Spain), M. Cobos Ceballos (Cordoba, Spain), F. Santos Luna (Cordoba, Spain), J. Vaquero Barrios (Cordoba, Spain). Evaluation of early conversion to prolonged-release tacrolimus in lung transplantation.. 2600

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Efficacy of tacrolimus rescue therapy in refractory acute rejection (AR) after lung transplantation
Source: Eur Respir J 2001; 18: Suppl. 33, 298s
Year: 2001

Early sirolimus immunosuppression is safe in lung transplantation
Source: Annual Congress 2012 - Optimising outcomes after lung transplantation
Year: 2012

Mycophenolate mofetil (MMF) rescue therapy in lung transplantation: results and pharmacokinetics
Source: Eur Respir J 2002; 20: Suppl. 38, 348s
Year: 2002

Evaluation of the biological effects of atorvastatin in lung transplant recipients
Source: Annual Congress 2007 - New insights into clinical lung transplantation
Year: 2007


Initial treatment with CsA-AZA versus FK506-MPA: Comparison of early outcomes after lung transplantation
Source: Annual Congress 2013 –Clinical studies in lung transplantation
Year: 2013

Aerosolized liposomal cyclosporine A for treatment of progressive allograft dysfunction following lung transplantation
Source: Annual Congress 2013 –Clinical studies in lung transplantation
Year: 2013


Azathioprine discontinuation and medium and long term outcomes after lung transplantation
Source: International Congress 2015 – Outcomes of lung transplantation
Year: 2015


Tacrolimus versus cyclosporine for lung transplant recipients in Portugal
Source: Virtual Congress 2020 – Clinical management of lung transplant recipients
Year: 2020


Mycophenolate mofetil reduces alveolar inflammation and acute rejection and improves overall outcome after lung transplantation
Source: Eur Respir J 2006; 28: Suppl. 50, 724s
Year: 2006

Comparison of post renal transplant tuberculosis cases receiving conventional immunosupressive therapy and mycophenolat mofetil (MMF) and/or tacrolimus (TAC)
Source: Eur Respir J 2003; 22: Suppl. 45, 157s
Year: 2003

Assessment of lung deposition and pharmacokinetics in 12 lung transplanted patients after inhalation of a novel liposomal ciclosporin a (CsA) formulation by the eFlow electronic nebuliser
Source: Eur Respir J 2007; 30: Suppl. 51, 29s
Year: 2007

LATE-BREAKING ABSTRACT: Long-term survival with extracorporeal photochemotherapy in lung transplant rejection patients not responsive to conventional treatment.
Source: International Congress 2014 – Novel approaches in the management of lung transplant candidates and recipients
Year: 2014

Curcumin in combination with low-dose cyclosporine a in experimental airway transplantation
Source: Eur Respir J 2007; 30: Suppl. 51, 518s
Year: 2007

Results of switch from mycophenolate mofetil to azathioprin after lung transplantation
Source: Eur Respir J 2004; 24: Suppl. 48, 178s
Year: 2004

The influence of different immunosuppressive regimen on non-mnestic cognitive functions in patients after lung transplantation
Source: International Congress 2014 – Maximise lung transplant outcomes: pre- and post-operative issues
Year: 2014

LATE-BREAKING ABSTRACT: Challenging immunosuppression treatment in lung transplant patients with kidney failure: Rescue therapy with basiliximab?
Source: International Congress 2015 – Pathogenic mechanisms of lung transplant complications: a focus on CLAD
Year: 2015


Effects of basiliximab and triple therapy on airway mucociliary clearance of rats
Source: International Congress 2014 – Novel approaches in the management of lung transplant candidates and recipients
Year: 2014


Azithromycin (Azi) treatment for chronic allograft dysfunction after lung transplantation (LTx)
Source: Annual Congress 2003 - Bronchiolitis obliterans: diagnosis and treatment
Year: 2003


Respiratory and renal functional evolutionary profiles after introduction of everolimus and minimizing doses of calcineurin inhibitors in lung transplant recipients, a descriptive observational study
Source: International Congress 2015 – Outcomes of lung transplantation
Year: 2015


Effect of TLI during azithromycin treatment in patients with BOS after lung transplantation
Source: Eur Respir J 2007; 30: Suppl. 51, 174s
Year: 2007